Vangelis Karalis

Associate Professor

Ethniko kai Kapodistriako Panepistemio Athenon Iatrike Schole

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vangelis Karalis is an Associate Professor at Ethniko kai Kapodistriako Panepistemio Athenon Schole Epistemon Ygeias in Greece. His research focuses on the intersection of artificial intelligence and bioequivalence, with recent articles exploring generative adversarial networks, machine learning applications, and innovative methods for enhancing clinical trials. He has contributed significantly to understanding drug-absorption rates and the complexities of highly variable drugs. His work aims to advance the integration of artificial intelligence into clinical practice.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Marilena Vlachou

National and Kapodistrian University of Athens

GREECE

View details

George Lambrou

Laboratory Teaching Faculty, Researcher

National and Kapodistrian University of Athens

GREECE

View details

Yannis Dotsikas

Associate Professor of Pharmaceutical Analysis

National and Kapodistrian University of Athens Faculty of Pharmacy

GREECE

View details

Ioannis Papassotiriou

National and Kapodistrian University of Athens

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vangelis Karalis

Research Interests

Contact this professor

About

Articles (20)

Artificial Intelligence Meets Bioequivalence: Using Generative Adversarial Networks for Smarter, Smaller Trials

Generative Neural Networks for Addressing the Bioequivalence of Highly Variable Drugs

Average Slope vs. Cmax: Which Truly Reflects the Drug-Absorption Rate?

A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence

Bioequivalence Studies of Highly Variable Drugs: An Old Problem Addressed by Artificial Neural Networks

Implementation of a Generative AI Algorithm for Virtually Increasing the Sample Size of Clinical Studies

Machine Learning in Allergic Contact Dermatitis: Identifying (Dis)similarities between Polysensitized and Monosensitized Patients

Type I Diabetes Mellitus Suppresses Experimental Skin Carcinogenesis

Introducing an Artificial Neural Network for Virtually Increasing the Sample Size of Bioequivalence Studies

The Integration of Artificial Intelligence into Clinical Practice

Dried Blood Spots in Neonatal Studies: A Computational Analysis for the Role of the Hematocrit Effect

Variational Autoencoders for Data Augmentation in Clinical Studies

An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence

Modeling the Double Peak Phenomenon in Drug Absorption Kinetics: The Case of Amisulpride

Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222

The Pharmacokinetics of Levetiracetam in Critically Ill Adult Patients: An Intensive Care Unit Clinical Study

Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals

3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications

High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events

Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers

Collaborators (4)

Marilena Vlachou

George Lambrou

Yannis Dotsikas

Ioannis Papassotiriou

Make your next move.